LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENTLicense, Development and Commercialization Agreement • November 2nd, 2007 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
This LICENSE, DEVELOPMENT and COMMERCIALIZATION AGREEMENT (this “Agreement”), having a date of October 30, 2007 (the “Execution Date”), is made by and between Acura Pharmaceuticals, Inc. (“Acura”), a New York corporation, having its principal place of business at 616 N. North Court, Suite 120, Palatine, IL 60067, and King Pharmaceuticals Research and Development, Inc. (“King”), a Delaware corporation and wholly owned subsidiary of King Pharmaceuticals, Inc., having a place of business at 4000 CentreGreen Way, Cary, NC 27513.
